Works matching Olanzapine

Results: 5000

Olanzapine optimal dose: Results of an open-label multicenter study in schizophrenic patients.

Published in:

Psychiatry & Clinical Neurosciences, 2000, v. 54, n. 4, p. 467, doi. 10.1046/j.1440-1819.2000.00738.x

By:

Ishigooka, Jun;
Murasaki, Mitsukuni;
Miura, Sadanori;
Group, The Olanzapine Late‐Phase Ii Study

Publication type:

Article

Olanzapine alleviates oxidative stress in the liver of socially isolated rats.

Published in:

Canadian Journal of Physiology & Pharmacology, 2017, v. 95, n. 6, p. 634, doi. 10.1139/cjpp-2016-0598

By:

Stanisavljevic, Andrijana;
Peric, Ivana;
Pantelic, Marija;
Filipovic, Dragana M.

Publication type:

Article

Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial.

Published in:

2008

By:

van Nimwegen, Lonneke J.;
de Haan, Lieuwe;
van Beveren, Nico J. M.;
van der Helm, Mischa;
van den Brink, Wim;
Linszen, Don;
van Beveren, Nico Jm

Publication type:

journal article

THE EFFICACY OF OLANZAPINE IN PATIENTS WITH SCHIZOFRENIA.

Published in:

Medical Journal / Medicinski Žurnal, 2011, v. 17, n. 2, p. 153

By:

Bravo-Mehmedbašić, Alma;
Kučukalić, Abdulah;
Fadilpašić, Senadin

Publication type:

Article

Augmentation of olanzapine in treatment-resistant schizophrenia.

Published in:

Journal of Pediatric Psychology, 2005, v. 30, n. 8, p. 409

By:

Zink, Mathias

Publication type:

Article

Olanzapine use for the treatment of adolescents with anorexia nervosa – reflecting on research and clinical practice.

Published in:

Journal of the Canadian Academy of Child & Adolescent Psychiatry, 2024, v. 33, n. 3, p. 164

By:

Spettigue, Wendy;
Norris, Mark L.

Publication type:

Article

Evaluation of the Effectiveness and Safety of Olanzapine as an Adjunctive Treatment for Anorexia Nervosa in Adolescents: An Open-Label Trial.

Published in:

Journal of the Canadian Academy of Child & Adolescent Psychiatry, 2018, v. 27, n. 3, p. 197

By:

Spettigue, Wendy;
Norris, Mark L;
Maras, Danijela;
Obeid, Nicole;
Feder, Stephen;
Harrison, Megan E;
Gomez, Rebecca;
Fu, Maeghan C. Y.;
Henderson, Katherine;
Buchholz, Annick

Publication type:

Article

Restless legs syndrome in a bipolar disorder patient treated with olanzapine: is there an association?

Published in:

2015

By:

BUTURAK, Şadiye Visal;
TİRYAKİ, Duygu;
DAĞ, Ersel;
TÜRKEL, Yakup

Publication type:

Case Study

Olanzapinle ılişkili Periferik Ödem: Olgu Sunumu.

Published in:

2008

By:

Atasoy, Nuray;
Karaahmet, Elif;
Konuk, Numan;
Atik, Levent;
Erdoğan, Ayten

Publication type:

Case Study

Therapeutic study of the nausea and vomiting caused by chemotherapy medications by olanzapine to triple antiemetic therapy in Iraqi cancer patients.

Published in:

Al-Mustansiriyah Journal for Pharmaceutical Sciences, 2023, v. 23, n. 2, p. 117, doi. 10.32947/ajps.v23i2.1013

By:

ahmed, Ghufran salah;
khadim, khadim ali;
talib, nabeel mudheher

Publication type:

Article

Lower weight gain with the orally disintegrating olanzapine than with standard tablets in first-episode never treated psychotic patients.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2007, v. 22, n. 1, p. 11, doi. 10.1002/hup.819

By:

Arranz, B.;
San, L.;
Dueñas, R. M.;
Centeno, M.;
Ramirez, N.;
Salavert, J.;
Del Moral, E.

Publication type:

Article

Olanzapine long-acting injection: a review of first experiences of post-injection delirium/sedation syndrome in routine clinical practice.

Published in:

BMC Psychiatry, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12888-015-0450-9

By:

Bushe, Chris J.;
Falk, Deborah;
Anand, Ernie;
Casillas, Marta;
Perrin, Elena;
Chhabra-Khanna, Rashna;
Detke, Holland C.

Publication type:

Article

Predictors of psychiatric hospitalization during 6 months of maintenance treatment with olanzapine long-acting injection: post hoc analysis of a randomized, double-blind study.

Published in:

BMC Psychiatry, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-244X-13-224

By:

Ascher-Svanum, Haya;
Novick, Diego;
Haro, Josep Maria;
Bertsch, Jordan;
McDonnell, David;
Detke, Holland

Publication type:

Article

POLIMORFIZMY GENETYCZNE A EFEKTY METABOLICZNE DZIAŁANIA OLANZAPINY.

Published in:

State & Society / Państwo i Społeczeństwo, 2023, v. 23, n. 1, p. 151, doi. 10.48269/2451-0858-pis-2023-1-011

By:

Sadakierska-Chudy, Anna;
Bartosiewicz, Angelika

Publication type:

Article

Účinnost/bezpečnost olanzapinu v tabletách dispergovatelných v ústech.

Published in:

Psychiatrie Pro Praxi, 2022, v. 23, n. 5, p. 187

By:

Boček, Jonáš

Publication type:

Article

Antipsychotics inhibit glucose transport: Determination of olanzapine binding site in Staphylococcus epidermidis glucose/H+ symporter.

Published in:

FEBS Open Bio, 2015, v. 5, p. 335, doi. 10.1016/j.fob.2015.04.006

By:

Babkin, Petr;
George Thompson, Alayna M.;
Iancu, Cristina V.;
Walters, D. Eric;
Choe, Jun-yong

Publication type:

Article

奥氮平联合舍曲林对于奥氮平血药浓度的影响研究.

Published in:

Evaluation & Analysis of Drug-Use in Hospitals of China / Zhongguo Yiyuan Yongyao Pingjia yu Fenxi, 2023, v. 23, n. 3, p. 264, doi. 10.14009/j.issn.1672-2124.2023.03.002

By:

胡晋卿;
肖桃;
朱秀清;
王占璋;
邓书华;
温预关;
尚德为

Publication type:

Article

Relationship Between Plasma Olanzapine and N-Desmethyl-Olanzapine Concentration and Metabolic Parameters in Patients With Schizophrenia.

Published in:

Frontiers in Psychiatry, 2022, v. 13, p. 1, doi. 10.3389/fpsyt.2022.930457

By:

Huimei An;
Hongzhen Fan;
Yajun Yun;
Song Chen;
Siyuan Qi;
Botao Ma;
Jing Shi;
Zhiren Wang;
Fude Yang

Publication type:

Article

Intramuscular olanzapine: a review of its use in the management of acute agitation.

Published in:

2005

By:

Wagstaff, Antona J.;
Easton, Jane;
Scott, Lesley J.

Publication type:

journal article

Niveles de glucosa en modelo de rata diabética bajo el uso de olanzapina.

Published in:

Revista Neurologia, Neurocirugia y Psiquiatria, 2011, v. 44, n. 2, p. 57

By:

Iniestra Villa, Edgardo

Publication type:

Article

Olanzapine plus fluvoxamine and olanzapine alone for the treatment of an acute exacerbation of schizophrenia.

Published in:

Psychiatry & Clinical Neurosciences, 2004, v. 58, n. 4, p. 364, doi. 10.1111/j.1440-1819.2004.01269.x

By:

CHAICHAN, WARAWAT

Publication type:

Article

Olanzapine versus haloperidol in the treatment of patients with chronic schizophrenia: Results of the Japan multicenter, double-blind olanzapine trial.

Published in:

Psychiatry & Clinical Neurosciences, 2001, v. 55, n. 4, p. 403, doi. 10.1046/j.1440-1819.2001.00882.x

By:

Ishigooka, Jun;
Inada, Toshiya;
Miura, Sadanori

Publication type:

Article

Olanzapine Bağlı Obsesif-Kompülsif Semptomlar Oluşan Bir Capgras Sendromu Olgusu.

Published in:

Dicle Medical Journal / Dicle Tip Dergisi, 2019, v. 46, n. 2, p. 379, doi. 10.5798/dicletip.539908

By:

Ekmen, Betül Uyar

Publication type:

Article

Olanzapine and breast-feeding: changes of plasma concentrations of olanzapine in a breast-fed infant over a period of 5 months.

Published in:

Journal of Psychopharmacology, 2010, v. 24, n. 1, p. 121, doi. 10.1177/0269881108096504

By:

Whitworth, A.;
Stuppaeck, C.;
Yazdi, K.;
Kralovec, K.;
Geretsegger, C.;
Zernig, G.;
Aichhorn, W.

Publication type:

Article

Olanzapine Y ol CII Tardive Discontinuing, Clozapine Ile Treedaisy.

Published in:

Klinik Psikofarmakoloji Bulteni, 2009, v. 19, p. S262

By:

Ozan, Erol;
Oral, Elif;
Daloğlu, Ali Gökhan;
Aydın, Nazan;
Kırpınar, İsmet

Publication type:

Article

Şizofreni Hastalarında Olanzapine Yanıtla Sinaptozomla İlişkili Protein (SNAP-25) Gen Polimorfizmi İlişkisi.

Published in:

Klinik Psikofarmakoloji Bulteni, 2009, v. 19, p. S145

By:

Şengul, Cem;
Erdal, Emin;
Herken, Hasan;
Aydın, Nazan;
Karadağ, Şliz;
Barlas, Ömer;
Ergündü, Tuba Gökdogan

Publication type:

Article

Síndrome post-inyección por olanzapina de liberación retardada: Breve revisión a propósito de un caso.

Published in:

Actas Espanolas de Psiquiatria, 2013, v. 41, n. 1, p. 60

By:

Duran-Sindreu, Santiago F.;
Grasa-Bello, Eva;
Corripio-Collado, Illuminada;
Sauras-Quetcuti, Rosa B.;
Keymer-Gausset, Alejandro;
Roldán-Bejarano, Alexandra;
Alonso-Solís, Anna;
Figueras-Vilalta, María;
Álvarez-Martínez, Enric

Publication type:

Article

Síndrome post-inyección por olanzapina de liberación retardada: Breve revisión a propósito de un caso.

Published in:

2013

By:

Duran-Sindreu, Santiago F.;
Grasa-Bello, Eva;
Corripio-Collado, Illuminada;
Sauras-Quetcuti, Rosa B.;
Keymer-Gausset, Alejandro;
Roldán-Bejarano, Alexandra;
Alonso-Solís, Anna;
Figueras-Vilalta1, María;
Álvarez-Martínez, Enric

Publication type:

Case Study

Bioequivalence of Olanzapine Given in Combination With Samidorphan as a Bilayer Tablet (ALKS 3831) Compared With Olanzapine‐Alone Tablets: Results From a Randomized, Crossover Relative Bioavailability Study.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 4, p. 459, doi. 10.1002/cpdd.601

By:

Sun, Lei;
McDonnell, David;
Liu, Jianjun;
Moltke, Lisa

Publication type:

Article

Olanzapine-Induced Hyperprolactinemia: Two Case Reports.

Published in:

Frontiers in Pharmacology, 2019, p. 1, doi. 10.3389/fphar.2019.00846

By:

Barata, Pedro Cabral;
Santos, Mário João;
Melo, João Carlos;
Maia, Teresa

Publication type:

Article

Olanzapine. Pharmacokinetic and pharmacodynamic profile.

Published in:

1999

By:

Callaghan, J.T.;
Bergstrom, R.F.;
Ptak, L.R.;
Beasley, C.M.

Publication type:

journal article

Spectrum of binge eating symptomatology in patients treated with clozapine and olanzapine.

Published in:

Journal of Neural Transmission, 2003, v. 110, n. 1, p. 111, doi. 10.1007/s00702-002-0792-6

By:

Theisen, F. M.;
Linden, A.;
König, I. R.;
Martin, M.;
Remschmidt, H.;
Hebebrand, J.

Publication type:

Article

An economic model to understand the cost-effectiveness of olanzapine orally dispersible tablets (ODT) and olanzapine film coated tablets as a group compared with other oral atypical antipsychotics for treating schizophrenia in Morocco.

Published in:

Annals of General Psychiatry, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12991-024-00516-y

By:

Tazi, Ahmed;
Errachidi, Faouzi;
Sonawane, Dipesh;
Tahri, Ghizlane;
Rao, Sameer;
Mehta, Suyog

Publication type:

Article

Selective glucocorticoid receptor (type II) antagonist prevents and reverses olanzapine-induced weight gain.

Published in:

Diabetes, Obesity & Metabolism, 2010, v. 12, n. 6, p. 545, doi. 10.1111/j.1463-1326.2009.01185.x

By:

Belanoff, J. K.;
Blasey, C. M.;
Clark, R. D.;
Roe, R. L.

Publication type:

Article

Olanzapine/Samidorphan: New Drug Approved for Treating Bipolar I Disorder and Schizophrenia.

Published in:

Annals of Pharmacotherapy, 2022, v. 56, n. 9, p. 1049, doi. 10.1177/10600280211070330

By:

Monahan, Christie;
McCoy, Lindsey;
Powell, Jason;
Gums, John G.

Publication type:

Article

Acute Bipolar Depression: A Review of the Use of Olanzapine/Fluoxetine.

Published in:

Clinical Medicine Insights: Therapeutics, 2010, n. 2, p. 825, doi. 10.4137/CMT.S1945

By:

Bobo, William V.;
Jr., Richard A. Epstein.;
Shelton, Richard C.

Publication type:

Article

Effectiveness and safety of oral olanzapine treatment transitioned from rapid-acting intramuscular olanzapine for agitation associated with schizophrenia.

Published in:

Neuropsychiatric Disease & Treatment, 2018, v. 14, p. 1083, doi. 10.2147/NDT.S158339

By:

Katagiri, Hideaki;
Taketsuna, Masanori;
Kondo, Shinpei;
Kajimoto, Kenta;
Aoi, Etsuko;
Tanji, Yuka

Publication type:

Article

Switching to olanzapine long-acting injection from either oral olanzapine or any other antipsychotic: comparative post hoc analyses.

Published in:

Neuropsychiatric Disease & Treatment, 2013, v. 9, p. 1737, doi. 10.2147/NDT.S50635

By:

Ciudad, Antonio;
Anand, Ernie;
Berggren, Lovisa;
Casillas, Marta;
Schacht, Alexander;
Perrin, Elena

Publication type:

Article

Olanzapine-induced Pancytopenia: Case Report.

Published in:

Medical Journal of Dr. D.Y. Patil Vidyapeeth, 2024, v. 17, p. S377, doi. 10.4103/mjdrdypu.mjdrdypu_13_24

By:

Prajnashree, A;
Someshwar, S. K;
Sayed, Arfa A;
Abhirami, K P;
Nyamagoud, Sanatkumar B.

Publication type:

Article

Olanzapine Versus Quetiapine: Corrected QT Changes in Critically Ill Patients.

Published in:

Annals of Pharmacotherapy, 2025, v. 59, n. 6, p. 530, doi. 10.1177/10600280241290254

By:

Shen, Kaden;
Dube, Kevin M.;
DeGrado, Jeremy R.;
Szumita, Paul M.;
Lupi, Kenneth E.

Publication type:

Article

Therapeutic drug monitoring of olanzapine: Easy and reliable method for clinical correlation.

Published in:

Indian Journal of Pharmacology, 2021, v. 53, n. 1, p. 2, doi. 10.4103/ijp.IJP_114_20

By:

Junutula, Srinivas Pramod;
Dubasi, Sai Kiran;
Padide, Sai Geethika Reddy;
Miryala, Gireesh Kumar;
Koppolu, Manasa Soumya;
Sheshagiri, Sharvana Bhava Bandaru;
Eggadi, Venkateshwarlu

Publication type:

Article

Olanzapine-induced restless leg syndrome: A case report and review of literature.

Published in:

2014

By:

Basu, Aniruddha;
Kundu, Savita;
Khurana, Hitesh

Publication type:

Case Study

A suspected case of olanzapine induced hyponatremia.

Published in:

2014

By:

Bakhla, Ajay Kumar;
Guria, Rishi Tuhin;
Kumar, Abhishek

Publication type:

Case Study

Olanzapine-induced hepatopathy in albino rats: A newer model for screening putative hepatoprotective agents, namely silymarin.

Published in:

Indian Journal of Pharmacology, 2010, v. 42, n. 6, p. 376, doi. 10.4103/0253-7613.71924

By:

Sengupta, Parama;
Bagchi, Chiranjib;
Sharma, Abhishek;
Majumdar, G.;
Dutta, C.;
Tripathi, Santanu

Publication type:

Article

Olanzapine induced tardive dystonia.

Published in:

Indian Journal of Pharmacology, 2008, v. 40, n. 5, p. 237, doi. 10.4103/0253-7613.44158

By:

Aggarwal, Ashish;
Jiloha, R. C.

Publication type:

Article

A patient with schizophrenia presenting with post-lobotomy catatonia treated with olanzapine: a case report.

Published in:

Psychogeriatrics, 2017, v. 17, n. 3, p. 202, doi. 10.1111/psyg.12208

By:

Kumagai, Ryo;
Kitazawa, Maiko;
Ishibiki, Yoshiro;
Narumi, Kenji;
Ichimiya, Yosuke

Publication type:

Article

Effects of olanzapine during cognitive and emotional processing in schizophrenia: A review of functional magnetic resonance imaging findings.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2019, v. 34, n. 3, p. N.PAG, doi. 10.1002/hup.2693

By:

Del Fabro, Lorenzo;
Delvecchio, Giuseppe;
D'Agostino, Armando;
Brambilla, Paolo

Publication type:

Article

The effects of olanzapine treatment on brain regional glucose metabolism in neuroleptic-naive first-episode schizophrenic patients.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2016, v. 31, n. 6, p. 419, doi. 10.1002/hup.2558

By:

Yoshimuta, Hirofumi;
Nakamura, Masayuki;
Kanda, Eisuke;
Fujita, Seigo;
Takeuchi, Kouzou;
Fujimoto, Toshiro;
Nakabeppu, Yoshiaki;
Akasaki, Yasuaki;
Sano, Akira

Publication type:

Article

Post authorization safety study comparing quetiapine to risperidone and olanzapine.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2016, v. 31, n. 4, p. 304, doi. 10.1002/hup.2539

By:

Heintjes, Edith M.;
Overbeek, Jetty A.;
Penning‐van Beest, Fernie J. A.;
Brobert, Gunnar;
Herings, Ron M. C.

Publication type:

Article

SSRI-antipsychotic combination in psychotic depression: sertraline pharmacokinetics in the presence of olanzapine, a brief report from the STOP-PD study.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2016, v. 31, n. 3, p. 252, doi. 10.1002/hup.2532

By:

Davies, Simon J. C.;
Mulsant, Benoit H.;
Flint, Alastair J.;
Meyers, Barnett S.;
Rothschild, Anthony J.;
Whyte, Ellen M.;
Kirshner, Margaret M.;
Sorisio, Denise;
Pollock, Bruce G.;
Bies, Robert R.

Publication type:

Article